Authors


Ayesha Sajjad, MD

Latest:

Stroke Risk Tied to Subjective Memory Complaints

Inquiring about memory in older persons during routine clinical examination may identify persons who might be at higher risk for stroke.



Bert B. Vargas, MD

Latest:

A 3-Step Strategy for Enhancing Migraine Patient Care: Bert B. Vargas, MD, FAHS, FAAN

The associate vice president of neuroscience, US Medical Affairs at Eli Lilly talked about the "Think Talk Treat Migraine" program and the 3 vital actions for providers take to improve migraine care for their patients. [WATCH TIME: 3 minutes]


Bianca Bucci

Latest:

A Smartphone Approach to Alzheimer Disease Diagnosis and Progression

Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.


Bobby Lazzara, MD

Latest:

Readmissions in the Homeless Population

A large study may bring us closer to identifying interventions that can help the homeless population with neurologic disease.


Brady Pregerson, MD

Latest:

Post-coital Headache

A sudden severe headache with emesis brings a 35-year-old man to the ED. Research on his smart phone has satisfied him that this is a post-coital event and therefore, harmless. He refuses a lumbar puncture.


Christie Lang, BSN, RN-BC

Latest:

Tools to Offer TLC for Hatred of Sound

There is no approved screening tool for misophonia, but a case review can lead to a diagnosis. Several treatment options may aid in symptom management.


Chun Lim, MD, PhD

Latest:

A Smartphone Approach to Alzheimer Disease Diagnosis and Progression

Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.


Dan Press, MD

Latest:

A Smartphone Approach to Alzheimer Disease Diagnosis and Progression

Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.




Dee Rapposelli

Latest:

Concurrent CGRP Inhibitor and OnabotulinumtoxinA Therapy Boosts Relief in Severe Chronic Migraine

For years, study participants had been suffering with migraine symptoms and had failed at least three to five therapies before enrolling in the trial.


Doaa Hasan Ibrahim, MD

Latest:

Tingling, Numbness in Lower Limbs: A Case Study

What do these images suggest is the cause of bilateral lower limb symptoms of 4 months’ duration?


Donald G. Grosset, BSc, MBChB, MD

Latest:

Parkinson Medication Adherence is Suboptimal

Drugs often involve multiple daily doses with complex dosing regimens, but interventions that have been applied generically to patients with chronic diseases can be applied to these cases as well.


Emily Hirsch

Latest:

Are We Overdiagnosing ADHD?

How best ensure an accurate ADHD diagnosis in the absence of an established gold-standard or neuroimaging test or biomarker?


Eric J. Stieglitz, JD

Latest:

Smartphone Headache Diaries: Privacy Pros and Cons

Just how private is that information your patient records in a mobile headache diary?


Erini Makariou, MD

Latest:

Loss of Consciousness in an Elderly Woman With Prior CVA: What Cause?

Here, view results of CT of the head and axial FLAIR and axial diffusion-weighted MRI studies. What is in your differential? What is your diagnosis?


Evan Morris, PhD

Latest:

Movies Show Male, Female Brains Differ During Smoking

Men and women smoke for different reasons and activate different parts of the brain while smoking. These findings from “dopamine movies” could have implications for Parkinson disease.


Felicia C. Goldstein, PhD

Latest:

Controversy Continues Regarding PPI Use and Dementia

A dementia expert addresses current controversies on proton pump inhibitors.


Figure1

Latest:

Yellow Cerebrospinal Fluid

This yellow CSF was drawn from an HIV-positive man who presented with status epilepticus. What is the most likely cause?


Francisco J. Gomez, MD

Latest:

Update on Monitoring and Treating MS

Here's a handy synopsis of a “hands-on” review of the current state of monitoring disease and treatment decision making in patients with multiple sclerosis.


Glenn S. Hirsch, MD

Latest:

Are We Overdiagnosing ADHD?

How best ensure an accurate ADHD diagnosis in the absence of an established gold-standard or neuroimaging test or biomarker?


Grace Halsey

Latest:

Alzheimer Disease: 2 New Studies with Practical Implications

Try to stay current with the flood of published dementia studies these days and you may miss a few with human subjects. Here, a quick review of 2 non-animal analyses that might make you think differently in clinic tomorrow.


Greg Eghigian, PhD

Latest:

Making Sense of Left-Handedness: An Interview With Howard Kushner, PhD

The practice of forcing left-handers to use their right hand is a long as human history and found in most societies. In fact, the words “left” and “left-handed” are synonyms for “defective” or “sinister” in almost all the world’s languages. More in this interview.


Gregory Pontone, MD

Latest:

Impulse Control Disorder in Parkinson Disease: 3 Questions

Delirium, psychosis, impulse control disorders: these are among the psychiatric problems associated with dopaminergic medications that control PD motor symptoms. Take the quiz.


Heidi Anne Duerr, MPH

Latest:

Advances in Deep Brain Stimulation for Epilepsy

How does DBS differ from other methods of neuromodulation? This question and more in this Q&A with Dr Robert Gross, a neurosurgical primary investigator in an important trial.


Heidi Moawad, MD

Latest:

Managing Vestibular Migraine: Optimizing Diagnosis and Treatment

With a differential diagnosis that varies from patient to patient, identifying and treating vestibular migraine continues to challenge even the most experienced clinicians.


Helen Lavretsky, MD, MS

Latest:

9 Natural Supplements for Cognitive Impairment

Which vitamins and supplements have shown promise in treating dementia and preventing cognitive decline?


Howard D. Weiss, MD

Latest:

Psychosis in Parkinson Disease

A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.


J. David Spence MD, FRCPC, FAHA

Latest:

Taking a New Look at Resistant Atherosclerosis

The notion of “resistant atherosclerosis,” points to possible breakthroughs in research and treatment.

© 2025 MJH Life Sciences

All rights reserved.